Skip to content

Transcranial direct current stimulation on Pain, Disability and Quality of life in individuals with Low back pain

Transcranial direct current stimulation on Pain, Disability and Quality of life in individuals with Chronic non-specific low back pain: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8c62pnj
Enrollment
Unknown
Registered
2024-08-13
Start date
2022-11-08
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low back pain

Interventions

This is a two-arm, double-blind, randomized controlled clinical trial. The sample will consist of 46 individuals of both sexes, aged between 18 and 60 years old with DLCNE. Participants will be random
(2) Experimental group: 23 individuals will receive the active intervention that will be carried out twice a week for 10 weeks, totaling 20 sessions and will consist of the application of 20 minutes o

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 60 years; having non-specific chronic low back pain; having an average pain score greater than or equal to 4/10 on a numeric rating scale

Exclusion criteria

Exclusion criteria: Have specific spinal pathology (tumor, spondylolisthesis, fracture, herniated disc, etc.); nerve root pain; coexistence of major muscular, joint, neurological, or psychiatric conditions; having undergone back surgery; perform some treatment for non-specific chronic low back pain concomitantly with the study; making chronic use of analgesic opioids; present contraindications for tDCS; diabetes mellitus; uncontrolled hypertension; severe cardiovascular and/or pulmonary disease; pregnancy; malignant tumors

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: It is expected to find an improvement of 3 points in pain intensity, assessed by the visual analog scale (VAS). Data collected one week before the intervention, before and after each intervention session, and one week after the completion of the interventions.;Outcome found 1: A statistically significant reduction in pain intensity assessed by VAS in the active tDCS group was observed in relation to the placebo tDCS group (p=0.026).

Secondary

MeasureTime frame
Expected outcome 2: It is expected to find a statistically significant difference in disability rates, assessed by ODI and Roland Morris. Data collected one week before the intervention and one week after the completion of the interventions.;Outcome found 2: There was no difference between groups for the disability outcome, ODI (p=0.113) and RMDQ (p=0.285).

Countries

Brazil

Contacts

Public ContactRicardo Souza

Universidade Federal do Rio Grande do Norte

viniciussouzafisio@gmail.com+55 (84) 981119197

Outcome results

None listed

Source: REBEC (via WHO ICTRP)